Another safety incident triggers a halt to a pivotal Covid-19 vaccine study as J&J slams on the brakes
Johnson & Johnson has voluntarily ordered a halt to all of its Covid-19 vaccine studies so investigators can probe the unexplained illness of one of the people in their study.
In a statement put out Monday evening, the pharma giant said that it had paused further dosing, noting that “the participant’s illness is being reviewed and evaluated by the ENSEMBLE independent Data Safety Monitoring Board as well as our internal clinical and safety physicians.”
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 142,600+ biopharma pros reading Endpoints daily — and it's free.